Article

HHS Decides Not to Leapfrog to ICD-11

Word of the new ICD-10 compliance deadline came as welcome news to many in the healthcare realm — just not everyone.

There remains a corner of the industry that publicly asked the Department of Health and Human Services (HHS) to consider other alternatives, most notably ICD-11, before mandating a new deadline.

Read the full story: http://bit.ly/NAp9st

Source: Healthcare Finance News

Related Videos
Mei Wei, MD.
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Sandra Cueller, PharmD
Ticiana Leal, MD
James Chambers, PhD
Related Content
FDA website | Image Credit: © Postmodern Studio - stock.adobe.com
November 22nd 2024

FDA Accepts Resubmitted NDA for Ataluren in Nonsense Duchenne Muscular Dystrophy

Marco Meglio
The new drug application (NDA) includes data from a global placebo-controlled, 72-week study as well as findings from the STRIDE registry, an ongoing, observational, real-world study of ataluren in routine care.
Managed Care Cast
November 21st 2024

Frameworks for Advancing Health Equity: Wellness Way

Giuliana Grossi
The Wellness Way facility was designed to improve access to comprehensive outpatient care and address social determinants of health for a diverse patient population.
Air purifier | Image credit: Prathankarnpap - stock.adobe.com
November 22nd 2024

In-Room Air Purifiers Could Impact RSV Incidence Among Older Adults

Kennedy Ferruggia
Use of in-room air purifiers with HEPA-14 filters did not result in a significant reduction of acute respiratory infections.
Managed Care Cast
October 29th 2024

Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa

Giuliana Grossi
Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.
Palliative care | Image Credit: Chinnapong - stock.adobe.com
November 22nd 2024

Early Palliative Care Linked to Better End-of-Life Outcomes in Ovarian Cancer

Brooke McCormick
Initiating palliative care more than 3 months before death improves end-of-life outcomes for patients with ovarian cancer, highlighting the need for earlier interventions.
In the Press
November 22nd 2024

AJMC® in the Press, November 22, 2024

AJMC Staff
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo